Page 9 - Immunology_11_2021

Multi-Tasking S3

RAPID Relief

S3

• Fast-acting olopatadine HCL 1

• Long-acting mometasone furoate
1

• Relieves AR* symptoms
1

• Restores QoL**
2

• Optimal control of rhinitis has a beneficial

effect on asthma (UAD***)
3

*Allergic Rhinitis; **Quality of Life; *** United Airways Disease

References: 1. Patel P, Salaptek AM, Tantry SK. Effect of olopatadine-mometasone combination nasal spray on seasonal rhinitis symptoms in an environmental exposure
chamber study. American College of Allergy, Asthma & Immunology. 2019;122(2):160-166.e.1. 2. Gross GN, et al. Efficacy and safety of olopatadine-mometasone
combination nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol, 2019;122:630-638. 3. Donner CF. Inflammation and Infection of the
Upper and Lower Respiratory Tract: United Airways Disease. RT Magazine. https://rtmagazine.com/disorders-diseases/chronic-pulmonary-disorders/asthma/inflammation-
and-infection-in-the-upper-and-lower-respiratory-tract-united-airways-disease/ [Accessed Aug 2021]
S3 RYALTRIS (Nasal spray). Reg. no. 53/21.5.1/0457. Each spray delivers 600 µg olopatadine (as olopatadine hydrochloride) and 25 µg mometasone furoate (as
®
mometasone furoate monohydrate). Contains the preservative benzalkonium chloride 0,02 % w/w. Sugar free. For full prescribing information refer to the professional
information approved by the South African Health Products Regulatory Authority. Date of publication: 5 May 2020.
HCR: Glenmark Pharmaceuticals South Africa (Pty) Ltd. 2nd Floor, Building D, Stoneridge Office Park, 8 Greenstone Place, Greenstone, Edenvale, Gauteng, 1609.
(Office) +27 11 564 3900 www.glenmarkpharma.com. ZAR/08/2021/36

Glenmark, touching the lives of patients for over three decades.

2021/10/14 12:45
2021 RYALTRIS MODERN MEDICINE.indd 1 2021/10/14 12:45
2021 RYALTRIS MODERN MEDICINE.indd 1